Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s): N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc > When is this going to blow up?

<< Previous

Bullboard Posts

Next >>

Post by Skippy780on Jan 05, 2021 3:15pm

343 Views

Post# 32225698

When is this going to blow up?

Hi, I got in originally at 3.44 and bought more on the rise up around 4.80. I held on even when it reached $5.80 because I saw potential in this stream of medicine. Does anyone know when this has the potential to take off and become the new cannabis stock?

I don't understand why it's tanked $2 over the past month with all the success???

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading